Alveolar epithelial cell regeneration participates in luteolin alleviating acute lung injury via AMPK-PFKFB2 signaling-activated glycolysis

Luteolin (Lut) is a natural flavonoid derived from numerous Chinese herbal medicines, which has been shown to alleviate acute lung injury/acute respiratory distress syndrome (ALI/ARDS). Nevertheless, the specific mechanism through which it mediates alveolar repair during this pathological process has yet to be elucidated. In this study, network pharmacology was used to screen the effective components of traditional Chinese medicine for the treatment of ALI/ARDS, and the protective effect of Lut was observed by lipopolysaccharide (LPS)-induced ALI mouse model. The possible target protein and pathways of Lut were determined through proteomics and bioinformatics analysis. In addition, alveolar epithelial type (AT) 2 cells and three-dimensional alveolar organoid model were applied to explore the mechanisms of Lut in the repair of alveolar epithelium during ALI/ARDS. As a potential therapeutic agent for ALI/ARDS, Lut alleviated LPS-induced pulmonary edema in mice. Proteomic profiling combined with glucose metabolism assays in alveolar epithelial cells/organoids demonstrated that glycolysis-driven energy production was required for the Lut resolution of alveolar injury. Further bioinformatics analysis suggested that glycolysis-associated adenosine 5’-monophosphate-activated protein kinase (AMPK) might be involved in ALI/ARDS. Intriguingly, the proliferation of AT2 cells and their capacity to differentiate into AT1 cells were augmented following Lut administration, which was reversed when either an AMPK inhibitor was administrated or its binding kinase 6-phosphofructo-2-kinase/fructose − 2,6-bisphosphatase 2 (PFKFB2) was blocked. Lut may promote the regeneration of alveolar epithelial cells through enhancing glycolysis mediated by AMPK-PFKFB2 signaling pathway, thereby repairing the impaired alveoli and alleviating ALI/ARDS.

Authors

Institutions

Publication Details

Journal
Cell Biology and Toxicology
Published
2026-11-19
DOI
https://doi.org/10.1007/s10565-026-10374-x
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Alveolar epithelial cell regeneration participates in luteolin alleviating acute lung injury via AMPK-PFKFB2 signaling-activated glycolysis

Yan Ding, Yunmei Fu, Tong Yu, Hongguang Nie et al.
Cell Biology and Toxicology
Flavonoids in Medical Research
article

Alveolar epithelial cell regeneration participates in luteolin alleviating acute lung injury via AMPK-PFKFB2 signaling-activated glycolysis

Yan Ding, Yunmei Fu, Tong Yu, Hongguang Nie, Yong Cui, Zhenhuan Yin, Yili Liu
article en

Abstract

Luteolin (Lut) is a natural flavonoid derived from numerous Chinese herbal medicines, which has been shown to alleviate acute lung injury/acute respiratory distress syndrome (ALI/ARDS). Nevertheless, the specific mechanism through which it mediates alveolar repair during this pathological process has yet to be elucidated. In this study, network pharmacology was used to screen the effective components of traditional Chinese medicine for the treatment of ALI/ARDS, and the protective effect of Lut was observed by lipopolysaccharide (LPS)-induced ALI mouse model. The possible target protein and pathways of Lut were determined through proteomics and bioinformatics analysis. In addition, alveolar epithelial type (AT) 2 cells and three-dimensional alveolar organoid model were applied to explore the mechanisms of Lut in the repair of alveolar epithelium during ALI/ARDS. As a potential therapeutic agent for ALI/ARDS, Lut alleviated LPS-induced pulmonary edema in mice. Proteomic profiling combined with glucose metabolism assays in alveolar epithelial cells/organoids demonstrated that glycolysis-driven energy production was required for the Lut resolution of alveolar injury. Further bioinformatics analysis suggested that glycolysis-associated adenosine 5’-monophosphate-activated protein kinase (AMPK) might be involved in ALI/ARDS. Intriguingly, the proliferation of AT2 cells and their capacity to differentiate into AT1 cells were augmented following Lut administration, which was reversed when either an AMPK inhibitor was administrated or its binding kinase 6-phosphofructo-2-kinase/fructose − 2,6-bisphosphatase 2 (PFKFB2) was blocked. Lut may promote the regeneration of alveolar epithelial cells through enhancing glycolysis mediated by AMPK-PFKFB2 signaling pathway, thereby repairing the impaired alveoli and alleviating ALI/ARDS.

Cell Biology and Toxicology
Fourth Affiliated Hospital of China Medical University (CN), First Hospital of China Medical University (CN), China Medical University (CN)
Flavonoids in Medical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon